Keywords: preclinical, program, rhudex, nearing, completion, uk-based, avidex

Preclinical program for RhuDex nearing completion

Article | 10 January 2005

Print This

UK-based Avidex says that its preclinical program evaluating RhuDex as a therapy for rheumatoid arthritis is drawing to a close ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in